Literature DB >> 11573581

Recovery after remifentanil and sufentanil for analgesia and sedation of mechanically ventilated patients after trauma or major surgery.

S Soltész1, A Biedler, M Silomon, I Schöpflin, G P Molter.   

Abstract

We investigated the analgesic effect and the neurological recovery time after administration of remifentanil in mechanically ventilated patients in an intensive care unit. Twenty patients, after trauma or major surgery with no intracranial pathology, were randomized to receive either remifentanil/propofol (n=10) or sufentanil/propofol (n=10). A sedation score and a simplified pain score were used to assess adequate sedation and analgesia. Medication was temporarily stopped after 24 h. Immediately before and 10 and 30 min after, the degree of sedation and pain score were evaluated. Adequate analgesia and sedation was achieved with remifentanil 10.6 microg kg(-1) h(-1) and propofol 2.1 mg kg(-1) h(-1), or sufentanil 0.5 microg kg(-1) h(-1) and propofol 1.3 mg kg(-1) h(-1). The difference in propofol dose between groups was significant. Ten minutes after terminating the medication, the degree of sedation decreased significantly after remifentanil and all patients could follow simple commands. During the following 20 min, all patients with remifentanil emerged from sedation and complained of considerable pain. By contrast, in the sufentanil group, only six (7) responded to commands after 10 (30) min and their pain score remained essentially unchanged during the 30-min observation period. We conclude that, in contrast to sufentanil, remifentanil facilitates rapid emergence from analgesia and sedation, allowing a clinical neurological examination within 10-30 min in mechanically ventilated patients with no intracranial pathology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11573581     DOI: 10.1093/bja/86.6.763

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  12 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Preoperative administration of controlled-release oxycodone as a transition opioid for total intravenous anaesthesia in pain control after laparoscopic cholecystectomy.

Authors:  Guido Fanelli; Daniela Ghisi; Marco Berti; Raffaella Troglio; Andrea Ortu; Camilla Consigli; Andrea Casati
Journal:  Surg Endosc       Date:  2008-07-15       Impact factor: 4.584

3.  Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients.

Authors:  Frédéric Ethuin; Said Boudaoud; Isabelle Leblanc; Christian Troje; Olivier Marie; Jean-Claude Levron; Jean-Pierre Le Moing; Patrice Assoune; Benoit Eurin; Laurent Jacob
Journal:  Intensive Care Med       Date:  2003-08-16       Impact factor: 17.440

Review 4.  Remifentanil : a review of its analgesic and sedative use in the intensive care unit.

Authors:  Anna J Battershill; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

5.  Remifentanil for analgesia-based sedation in the intensive care unit.

Authors:  Ralf Kuhlen; Christian Putensen
Journal:  Crit Care       Date:  2003-12-17       Impact factor: 9.097

6.  Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment.

Authors:  Des Breen; Alexander Wilmer; Andrew Bodenham; Vagn Bach; Jan Bonde; Paul Kessler; Sven Albrecht; Soraya Shaikh
Journal:  Crit Care       Date:  2003-11-21       Impact factor: 9.097

7.  Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial [ISRCTN43755713].

Authors:  Bernd Muellejans; Angel López; Michael H Cross; César Bonome; Lachlan Morrison; Andrew J T Kirkham
Journal:  Crit Care       Date:  2003-11-20       Impact factor: 9.097

8.  Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497].

Authors:  Des Breen; Andreas Karabinis; Manu Malbrain; Rex Morais; Sven Albrecht; Inge-Lise Jarnvig; Pauline Parkinson; Andrew J T Kirkham
Journal:  Crit Care       Date:  2005-03-15       Impact factor: 9.097

9.  The effect of sufentanil administration on remifentanil-based anaesthesia during laparoscopic gynaecological surgery: a double-blind randomized controlled trial.

Authors:  Ilsoon Son; Chung-Sik Oh; Jae Won Choi; Seong-Hyop Kim
Journal:  ScientificWorldJournal       Date:  2014-05-13

Review 10.  The place for short-acting opioids: special emphasis on remifentanil.

Authors:  Wolfram Wilhelm; Sascha Kreuer
Journal:  Crit Care       Date:  2008-05-14       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.